Trial Profile
Phase II, randomized, blinded study of ibuprofen-PC [ibuprofen/phosphatidylcholine] and ibuprofen in patients with osteoarthritis to investigate efficacy and gastrointestinal toxicity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2008
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions
- Sponsors PLx Pharma
- 25 Nov 2008 Status changed from active, no longer recruiting to completed.
- 07 Nov 2006 New trial record.